Literature DB >> 954820

Des-Asp1-angiotensin I: a metabolite of angiotensin I in the perfused feline adrenal.

J A Ackerly, T S Felger, M J Peach.   

Abstract

The administration of radioactive angiotensin I to the retrogradely perfused feline adrenal gland caused a brisk discharge of catecholamines. Recovery of the labelled decapeptide and metabolites in the adrenal effluent fluid was complete in 5 min. Radioimmunoassay of this perfusate revealed that most of the peptide remained as angiotensin I, but chromatographic and electrophoretic evaluation indicated that greater than 68% of the peptide had been metabolized to des-asp1 -angiotensin I. The absence of des-asp1 -angiotensin II, angiotensin II or his-3H-leu in adrenal effluent fluid suggested minimal dipeptidyl carboxypeptidase activity in this preparation. In addition, the profile of angiotensin I metabolites from the perfused adrenal was not altered by treatment with a converting enzyme inhibitor B. jararaca nonapeptide. The des-asp1-angiotensin I peptide was a very weak secretagogue in the adrenal medulla. If metabolism of the decapeptide to the nonapeptide occurs in the medulla, this may represent a pathway to limit the secretory action of angiotensin I. These results suggest a high degree of adrenal aminopeptidase activity which may be primarily localized in the adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954820     DOI: 10.1016/0014-2999(76)90207-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Capillaries of the adrenal cortex possess aminopeptidase A and angiotensin-converting-enzyme activities.

Authors:  P J Del Vecchio; J W Ryan; A Chung; U S Ryan
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

2.  Influence of converting enzyme inhibition on the release of vasopressin induced by angiotensin.

Authors:  W Knepel; D K Meyer
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.